帮助 关于我们

返回检索结果

Induced Th2 dominant immune response in APPswe, PSEN1dE9 transgenic mice after nasal immunization with an adenoviral vector encoding 10 tandem repeats of beta-amyloid 3-10

查看参考文献30篇

Guo Rong 1   Huang Kui 2   Jiang Tongzi 1   Li Jian 3   Li Yu 1   Xing Xiaona 1   Cao Yunpeng 1 *  
文摘 Immunotherapy for Alzheimer’s disease (AD) is effective in improving cognitive function in transgenic mouse models of AD. Because the AN1792 [beta-amyloid (Aβ) 1-42] vaccine was halted because of T cell mediated meningoencephalitis, many scientists are searching for a novel vaccine to avoid the T cell mediated immune response caused by the Aβ1-42. Importantly, the time when the immunization is begun can influence the immune effect. In this study, an adenovirus vaccine was constructed containing 10 × Aβ3-10 repeats and gene adjuvant CpG DNA. Transgenic AD mice were immunized intranasally for 3 months. After 10 × Aβ3-10 vaccine immunization, high titers of anti-Aβ42 IgG1 predominant antibodies were induced. In spatial learning ability and probe tests, the 10 × Aβ3-10 immunized mice showed significantly improved memories compared to control mice. The 10 × Aβ3-10 vaccine resulted in a robust Th2 dominant humoral immune response and reduced learning deficits in AD mice. In addition, the 10 × Aβ3-10 vaccine might be more efficient if administered before Aβ aggregation at an early stage in the AD mouse brain. Thus, the adenovirus vector encoding 10 × Aβ3-10 is a promising vaccine for AD
来源 Neural Regeneration Research ,2011,6(26):2005-2012 【核心库】
DOI 10.3969/j.issn.1673-5374.2011.26.001
关键词 Alzheimer's disease ; immunotherapy ; gene vaccine ; amyloid plaque ; T cell immunity response ; neural regeneration
地址

1. Department of Neurology, First Affiliated Hospital of China Medical University, Liaoning, Shenyang, 110001  

2. Department of Neurology, Shenyang Red Cross Hospital, Liaoning, Shenyang, 110013  

3. Department of Neurology, First Affiliated Hospital of Liaoning Medical College, Liaoning, Jinzhou, 121001

语种 英文
文献类型 研究性论文
ISSN 1673-5374
学科 神经病学与精神病学
基金 国家自然科学基金
文献收藏号 CSCD:4363505

参考文献 共 30 共2页

1.  Wolfe M S. Shutting down Alzheimer’s. Sci Am,2006,294(5):72-79 被引 2 次    
2.  Schenk D. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature,1999,400(6740):173-177 被引 128 次    
3.  Orgogozo J M. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology,2003,61(1):46-54 被引 32 次    
4.  Nicoll J A. Neuropathology of human Alzheimer’ disease after immunization with amyloid-beta peptide a case report. Nat Med,2003,9(4):448-452 被引 38 次    
5.  Ferrer I. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol,2004,14(1):11-20 被引 12 次    
6.  Holmes C. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet,2008,372(9634):216-223 被引 37 次    
7.  Vellas B. Long-term follow-up of patients immunized with AN1792:reduced functional decline in antibody responders. Curr Alzheimer Res,2009,6(2):144-151 被引 8 次    
8.  Mclaurin J. Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat Med,2002,8(11):1263-1269 被引 25 次    
9.  Monsonego A. Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease. J.Clin Invest,2003,112(3):415-422 被引 21 次    
10.  Frenkel D. Generation of auto-antibodies towards Alzheimer’s disease vaccination. Vaccine,2001,19(17/19):2615-2619 被引 11 次    
11.  Kim H D. Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid β-protein and GM-CSF. Vaccine,2005,23(23):2977-2986 被引 7 次    
12.  Kim H D. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Aβ1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer disease. J Gene Med,2007,9(2):88-98 被引 6 次    
13.  Yamamoto S. CpG motif and tuberculosis immunity. Kekkaku,2010,85(6):515-522 被引 1 次    
14.  Weiner H L. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in amouse model of Alzheimer’s disease. Ann Neurol,2000,48(4):567-579 被引 7 次    
15.  Cribbs D H. Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with betaamyloid. Int Immunol,2003,15(4):505-514 被引 18 次    
16.  Lemere C A. Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer’s disease. DNA Cell Biol,2001,20(11):705-711 被引 4 次    
17.  Bowers W J. Amyloid immunotherapy-engendered CNS inflammation. Neurobiol Aging,2002,23(5):683-674 被引 1 次    
18.  Lemere C A. Developing novel immunogens for a safe and effective Alzheimer’s disease vaccine. Prog Brain Res,2009,175:83-93 被引 7 次    
19.  Seabrook T J. Boosting with intranasal dendrimeric Abeta1-15 but not Abeta1-15 peptide leads to an effective immune response following a single injection of Abeta1-40/42 in APP-tg mice. J Neuroinflammation,2006,3:14 被引 1 次    
20.  Maier M. Short Amyloid-β(Aβ) immunogens reduce cerebral Aβ load and learning deficits in an Alzheimer’s disease mouse model in the absence of an Aβ-specific cellular immune response. J Neurosci,2006,26(18):4717-4728 被引 6 次    
引证文献 1 篇

1 Jiang Tongzi Nasal mucosal inhalation of amyloid-beta peptide 3-10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1-42) Neural Regeneration Research,2014,9(8):872-877
被引 0 次

显示所有1篇文献

论文科学数据集
PlumX Metrics
相关文献

 作者相关
 关键词相关
 参考文献相关

版权所有 ©2008 中国科学院文献情报中心 制作维护：中国科学院文献情报中心
地址：北京中关村北四环西路33号 邮政编码：100190 联系电话：(010)82627496 E-mail:cscd@mail.las.ac.cn 京ICP备05002861号-4 | 京公网安备11010802043238号